{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:02:09Z","timestamp":1784779329035,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04434-z","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:05:21Z","timestamp":1779793521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the impacts of docetaxel and paclitaxel based neoadjuvant therapies on early postoperative complications in HER2-positive breast cancer patients"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3598-1625","authenticated-orcid":false,"given":"Mehmet Furkan","family":"Sagdic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2177-7065","authenticated-orcid":false,"given":"Emre","family":"Tunc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5418-507X","authenticated-orcid":false,"given":"Seher","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2293-7139","authenticated-orcid":false,"given":"Mahmut Onur","family":"Kulturoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4139-067X","authenticated-orcid":false,"given":"\u00d6zgen Ahmet","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3834-0911","authenticated-orcid":false,"given":"Lutf\u0131","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"3","key":"4434_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10087","key":"4434_CR2","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","volume":"389","author":"S Loibl","year":"2017","unstructured":"Loibl S, Gianni L. HER2-positive breast cancer. Lancet. 2017;389(10087):2415\u201329.","journal-title":"Lancet"},{"issue":"5","key":"4434_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22(5):331\u201357.","journal-title":"J Natl Compr Canc Netw"},{"key":"4434_CR4","unstructured":"Ferguson T, Ghersi D, Nowak AK, Wilcken N. Taxanes for adjuvant treatment of early breast cancer. Cochrane Database Syst Rev. 2019;(9):CD004421."},{"issue":"5","key":"4434_CR5","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/annonc\/mdz061","volume":"30","author":"T Bachelot","year":"2019","unstructured":"Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, et al. Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). Ann Oncol. 2019;30(5):766\u201373.","journal-title":"Ann Oncol"},{"issue":"10","key":"4434_CR6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.annonc.2021.06.024","volume":"32","author":"D Miles","year":"2021","unstructured":"Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, et al. Final results from the PERUSE study. Ann Oncol. 2021;32(10):1245\u201355.","journal-title":"Ann Oncol"},{"issue":"5","key":"4434_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1200\/JCO.2014.57.1745","volume":"33","author":"C Dang","year":"2015","unstructured":"Dang C, Iyengar N, Datko F, D\u2019Andrea G, Theodoulou M, Dickler M, et al. Phase II study of weekly paclitaxel with trastuzumab and pertuzumab. J Clin Oncol. 2015;33(5):442\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4434_CR8","first-page":"290","volume":"67","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, et al. Breast cancer staging updates. CA Cancer J Clin. 2017;67(4):290\u2013303.","journal-title":"CA Cancer J Clin"},{"issue":"4785","key":"4434_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer and HER2. Science. 1987;235(4785):177\u201382.","journal-title":"Science"},{"issue":"3","key":"4434_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ctrv.2012.04.008","volume":"39","author":"SA Hurvitz","year":"2013","unstructured":"Hurvitz SA, Hu Y, O\u2019Brien N, Finn RS. Current approaches in HER2-positive breast cancer. Cancer Treat Rev. 2013;39(3):219\u201329.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"4434_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jnci\/dji021","volume":"97","author":"D Mauri","year":"2005","unstructured":"Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant vs adjuvant therapy. J Natl Cancer Inst. 2005;97(3):188\u201394.","journal-title":"J Natl Cancer Inst"},{"key":"4434_CR12","doi-asserted-by":"publisher","first-page":"622621","DOI":"10.3389\/fonc.2021.622621","volume":"11","author":"S Keelan","year":"2021","unstructured":"Keelan S, Flanagan M, Hill AD. Trends in breast cancer surgery. Front Oncol. 2021;11:622621.","journal-title":"Front Oncol"},{"key":"4434_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10549-006-9306-9","volume":"101","author":"G Gasparini","year":"2007","unstructured":"Gasparini G, Gion M, Mariani L, Papaldo P, Crivellari D, Filippelli G, et al. Weekly paclitaxel trial. Breast Cancer Res Treat. 2007;101:355\u201365.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"4434_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/jnci\/djh131","volume":"96","author":"MD Pegram","year":"2004","unstructured":"Pegram MD, Konecny GE, O\u2019Callaghan C, Beryt M, Pietras R, Slamon DJ. Trastuzumab combinations. J Natl Cancer Inst. 2004;96(10):739\u201349.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"4434_CR15","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Chemotherapy plus trastuzumab. N Engl J Med. 2001;344(11):783\u201392.","journal-title":"N Engl J Med"},{"issue":"5","key":"4434_CR16","doi-asserted-by":"crossref","first-page":"e13987","DOI":"10.1111\/ijcp.13987","volume":"75","author":"MA Gulcelik","year":"2021","unstructured":"Gulcelik MA, Dogan L. Oncoplastic techniques feasibility. Int J Clin Pract. 2021;75(5):e13987.","journal-title":"Int J Clin Pract"},{"key":"4434_CR17","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1245\/s10434-019-07408-6","volume":"26","author":"K Adamson","year":"2019","unstructured":"Adamson K, Chavez-MacGregor M, Caudle A, Smith B, Baumann D, Liu J, et al. Neoadjuvant chemotherapy complications. Ann Surg Oncol. 2019;26:2730\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4434_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejso.2021.09.007","volume":"48","author":"T Lorentzen","year":"2022","unstructured":"Lorentzen T, Heidemann LN, Moeller S, Bille C. Meta-analysis of surgical complications. Eur J Surg Oncol. 2022;48(1):44\u201352.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"4434_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/jso.26301","volume":"123","author":"MR Woeste","year":"2021","unstructured":"Woeste MR, Bhutiani N, Donaldson M, McMasters KM, Ajkay N. Surgical outcomes after breast-conserving surgery. J Surg Oncol. 2021;123(2):439\u201345.","journal-title":"J Surg Oncol"},{"issue":"3","key":"4434_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ctrv.2015.02.003","volume":"41","author":"L Carbognin","year":"2015","unstructured":"Carbognin L, Sperduti I, Nortilli R, Brunelli M, Vicentini C, Pellini F, et al. Taxane sensitivity analysis. Cancer Treat Rev. 2015;41(3):262\u201370.","journal-title":"Cancer Treat Rev"},{"key":"4434_CR21","doi-asserted-by":"crossref","unstructured":"Sharma P, Kimler BF, O'Dea A, Nye LE, Wang YY, Yoder R, et al. Results of randomized phase II trial of neoadjuvant carboplatin plus docetaxel or carboplatin plus paclitaxel followed by AC in stage I-III triple-negative breast cancer (NCT02413320). J Clin Oncol. 2019;37(15 Suppl):516.","DOI":"10.1200\/JCO.2019.37.15_suppl.516"},{"key":"4434_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s10637-020-01029-7","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen Y, Bao B, Lv Y, Sun D, Zhang L, Wang J, et al. Nab-paclitaxel versus docetaxel. Invest New Drugs. 2021;39:524\u20139.","journal-title":"Invest New Drugs"},{"issue":"4 Suppl","key":"4434_CR23","first-page":"P5","volume":"77","author":"Y Zong","year":"2017","unstructured":"Zong Y, Wu J, Shen K. Nab-paclitaxel meta-analysis. Cancer Res. 2017;77(4 Suppl):P5\u201316.","journal-title":"Cancer Res"},{"key":"4434_CR24","doi-asserted-by":"publisher","first-page":"1412051","DOI":"10.3389\/fonc.2024.1412051","volume":"14","author":"Z Lyu","year":"2024","unstructured":"Lyu Z, Gao L. Real-world HER2-positive study. Front Oncol. 2024;14:1412051.","journal-title":"Front Oncol"},{"key":"4434_CR25","doi-asserted-by":"publisher","first-page":"760655","DOI":"10.3389\/fonc.2021.760655","volume":"11","author":"ZD Lv","year":"2022","unstructured":"Lv ZD, Song HM, Niu ZH, Nie G, Zheng S, Xu YY, et al. Albumin-bound paclitaxel study. Front Oncol. 2022;11:760655.","journal-title":"Front Oncol"},{"issue":"3","key":"4434_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/sj.bjc.6603872","volume":"97","author":"F Puisset","year":"2007","unstructured":"Puisset F, Alexandre J, Treluyer JM, Raoul V, Roche H, Goldwasser F, et al. Clinical pharmacodynamic factors in docetaxel toxicity. Br J Cancer. 2007;97(3):290\u20136.","journal-title":"Br J Cancer"},{"issue":"7","key":"4434_CR27","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1172\/JCI124616","volume":"129","author":"M Peiseler","year":"2019","unstructured":"Peiseler M, Kubes P. Neutrophils in tissue repair. J Clin Invest. 2019;129(7):2629\u201339.","journal-title":"J Clin Invest"},{"key":"4434_CR28","doi-asserted-by":"crossref","unstructured":"Rizo-T\u00e9llez SA, Filep JG. Beyond host defense and tissue injury: the emerging role of neutrophils in tissue repair. Am J Physiol Cell Physiol. 2024;326(3):C661\u201383.","DOI":"10.1152\/ajpcell.00652.2023"},{"issue":"4","key":"4434_CR29","doi-asserted-by":"publisher","first-page":"e0215576","DOI":"10.1371\/journal.pone.0215576","volume":"14","author":"Y Furuya","year":"2019","unstructured":"Furuya Y. Early neutropenia mechanisms. PLoS ONE. 2019;14(4):e0215576.","journal-title":"PLoS ONE"},{"issue":"9","key":"4434_CR30","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1158\/1535-7163.MCT-06-0242","volume":"5","author":"MN Bijman","year":"2006","unstructured":"Bijman MN, van Nieuw Amerongen GP, Laurens N, van Hinsbergh VW, Boven E. Microtubule-targeting agents inhibit angiogenesis. Mol Cancer Ther. 2006;5(9):2348\u201357.","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"4434_CR31","first-page":"1191","volume":"1","author":"KA Hotchkiss","year":"2002","unstructured":"Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL. Docetaxel inhibits angiogenesis. Mol Cancer Ther. 2002;1(13):1191\u2013200.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"4434_CR32","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3748\/wjg.v9.i9.1995","volume":"9","author":"XL Guo","year":"2003","unstructured":"Guo XL, Lin GJ, Zhao H, Gao Y, Qian LP, Xu SR, et al. Inhibitory effects of docetaxel on VEGF. World J Gastroenterol. 2003;9(9):1995\u20139.","journal-title":"World J Gastroenterol"},{"issue":"24 Suppl","key":"4434_CR33","first-page":"P1","volume":"72","author":"D Mavroudis","year":"2012","unstructured":"Mavroudis D, Malamos N, Boukovinas I, Kakolyris S, Kourousis C, Athanasiadis A, et al. Randomized study. Cancer Res. 2012;72(24 Suppl):P1\u201313.","journal-title":"Cancer Res"},{"key":"4434_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10549-014-3202-5","volume":"148","author":"E Saloustros","year":"2014","unstructured":"Saloustros E, Malamos N, Boukovinas I, Kakolyris S, Kouroussis C, Athanasiadis A, et al. Dose-dense paclitaxel vs docetaxel. Breast Cancer Res Treat. 2014;148:591\u20137.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4434_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.critrevonc.2009.07.001","volume":"75","author":"B Beuselinck","year":"2010","unstructured":"Beuselinck B, Wildiers H, Wynendaele W, Dirix L, Kains JP, Paridaens R. Weekly taxane study. Crit Rev Oncol Hematol. 2010;75(1):70\u20137.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Suppl","key":"4434_CR36","first-page":"Abstract","volume":"41","author":"MS Trivedi","year":"2023","unstructured":"Trivedi MS, Unger JM, Hershman DL, Darke A, Hertz DL, Brannagan T, et al. Chemotherapy-induced peripheral neuropathy. J Clin Oncol. 2023;41(Suppl):Abstract.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4434_CR37","first-page":"352","volume":"19","author":"M Maemondo","year":"2014","unstructured":"Maemondo M, Inoue A, Sugawara S, Harada T, Minegishi Y, Usui K, et al. Lung cancer trial Oncologist. 2014;19(4):352\u20133.","journal-title":"Lung cancer trial Oncologist"},{"issue":"24 Suppl","key":"4434_CR38","first-page":"PD07","volume":"71","author":"T Watanabe","year":"2011","unstructured":"Watanabe T, Kuranami M, Inoue K, Masuda N, Aogi K, Ohno S, et al. NSAS-BC trial. Cancer Res. 2011;71(24 Suppl):PD07\u201302.","journal-title":"Cancer Res"},{"issue":"9 Suppl","key":"4434_CR39","first-page":"S3","volume":"75","author":"JA Sparano","year":"2015","unstructured":"Sparano JA, Zhao F, Martino S, Ligibel J, Saphner T, Wolff AC, et al. E1199 trial update. Cancer Res. 2015;75(9 Suppl):S3\u201303.","journal-title":"Cancer Res"},{"issue":"3","key":"4434_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0022034509359125","volume":"89","author":"S Guo","year":"2010","unstructured":"Guo S, DiPietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219\u201329.","journal-title":"J Dent Res"},{"issue":"9","key":"4434_CR41","first-page":"3924","volume":"5","author":"S Panigrahi","year":"2017","unstructured":"Panigrahi S, Sethy S, Bhoi SS, Panigrahi M. Factors affecting wound healing after laparotomy at a tertiary care hospital, Odisha, India: a prospective interventional study. Int J Res Med Sci. 2017;5(9):3924\u20138.","journal-title":"Int J Res Med Sci"},{"issue":"4","key":"4434_CR42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.18203\/2320-6012.ijrms20221000","volume":"10","author":"FN Rosyid","year":"2022","unstructured":"Rosyid FN. Wound healing mechanisms. Int J Res Med Sci. 2022;10(4):1001\u20136.","journal-title":"Int J Res Med Sci"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04434-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04434-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04434-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:18:05Z","timestamp":1784776685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04434-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4434"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04434-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data collection and methods implemented in this study adhered to the ethical guidelines established by both the institutional and national research committees. Furthermore, they complied with the principles outlined in the 1964 Helsinki Declaration and its subsequent revisions or equivalent ethical standards. Ethical approval was obtained from the Research Ethics Committee of Ankara Etlik City Hospital, University of Health Sciences (AE\u015eH-BADEK-2025-105). The data collection program for this study was approved by ethics committee with a waiver for individual informed consent for this retrospective study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"308"}}